Zeymer Uwe, Arntz Hans-Richard, Dirks Burkhardt, Ellinger Klaus, Genzwürker Harald, Nibbe Lutz, Tebbe Ulrich, Senges Jochen, Schneider Steffen
Herzzentrum Ludwigshafen, Germany; Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Ludwigshafen, Germany.
Resuscitation. 2009 Apr;80(4):402-6. doi: 10.1016/j.resuscitation.2008.12.004. Epub 2009 Jan 22.
We sought to evaluate the in-hospital fate of patients with ST segment elevation myocardial infarction (STEMI) diagnosed already in the prehospital phase by physican equipped ambulances.
A total of 2326 consecutive STEMI patients were included in PREMIR. For this analysis 218 patients with prehospital cardiopulmonary resuscitation were excluded.
The median time between symptom onset and 12-lead ECG was 85 min. The median time intervals between the diagnostic 12-lead ECG and prehospital fibrinolysis were 10 min, until inhospital fibrinolysis 52 min and until primar PCI 86min, respectively. Reperfusion therapy with prehospital fibrinolysis (24%), inhospital fibrinolysis (13%) or primary PCI (45%) was performed in 82% of the patients. Inhospital mortality was 6.0% in patients with prehospital fibrinolysis (n = 504), 5.8% in patients with inhospital fibrinolysis (n = 278), 4.5% in patients with primary percutaneous coronary intervention (n = 962) and 16.2% in patients without early reperfusion therapy (n = 377), respectively. In the multivariate propensity score analysis comparing prehospital fibrinolysis and primary PCI we observed no significant difference in the odds for in-hospital mortality (odds ratio: 1.57, 95% CI: 0.94-2.63). The final discharge diagnosis was STEMI in 90% of the patients, in patients with prehospital fibrinolysis 95%.
In patients with STEMI already diagnosed in the prehospital phase the ischemic time is short, accuracy of the diagnosis is high and reperfusion therapy is performed in over 82%. Inhospital mortality was not different between prehospital fibrinolysis and primary PCI.
我们试图评估由配备医生的救护车在院前阶段就已诊断出的ST段抬高型心肌梗死(STEMI)患者的院内转归情况。
共有2326例连续的STEMI患者纳入PREMIR研究。本次分析排除了218例进行过院前心肺复苏的患者。
症状发作至12导联心电图检查的中位时间为85分钟。诊断性12导联心电图至院前溶栓的中位时间间隔为10分钟,至院内溶栓为52分钟,至直接经皮冠状动脉介入治疗(PCI)为86分钟。82%的患者接受了院前溶栓(24%)、院内溶栓(13%)或直接PCI(45%)的再灌注治疗。院前溶栓患者(n = 504)的院内死亡率为6.0%,院内溶栓患者(n = 278)为5.8%,直接经皮冠状动脉介入治疗患者(n = 962)为4.5%,未接受早期再灌注治疗的患者(n = 377)为16.2%。在比较院前溶栓和直接PCI的多因素倾向评分分析中,我们观察到院内死亡几率无显著差异(优势比:1.57,95%可信区间:0.94 - 2.63)。90%的患者最终出院诊断为STEMI,院前溶栓患者中这一比例为95%。
对于在院前阶段就已诊断出的STEMI患者,缺血时间短,诊断准确性高,超过82%的患者接受了再灌注治疗。院前溶栓和直接PCI的院内死亡率无差异。